Michelle Gao

Michelle Gao is an accomplished Senior Quality Control Analyst at Novavax, with extensive experience in leading method qualification and technology transfer for ELISA-based assays since March 2021. Previously, Michelle served in various quality control roles at Catalent Pharma Solutions, MacroGenics, Inc., MESO SCALE DIAGNOSTICS, LLC., Trevigen, Inc., Maxim Biomedical, Inc., and DNA Technologies, contributing to assay development, method optimization, and regulatory compliance. Michelle holds an Associate of Arts and Sciences degree in Biotechnology from Montgomery College and has played a pivotal role in quality management and technology transfer processes throughout a diverse career in the biotechnology and pharmaceutical industries.